Literature DB >> 22056876

A retinoic acid receptor RARα pool present in membrane lipid rafts forms complexes with G protein αQ to activate p38MAPK.

A Piskunov1, C Rochette-Egly.   

Abstract

Retinoic acid (RA) regulates several gene programs by nuclear RA receptors (RARs) that are ligand-dependent transcriptional transregulators. The basic mechanism for switching on transcription of cognate-target genes involves RAR binding at specific response elements and a network of interactions with coregulatory protein complexes. In addition to these classical genomic effects, we recently demonstrated that RA also induces the rapid activation of the p38MAPK/MSK1 pathway, with characteristic downstream consequences on the phosphorylation of RARs and the expression of their target genes. Here, we aimed at deciphering the underlying mechanism of the rapid non-genomic effects of RA. We highlighted a novel paradigm in which a fraction of the cellular RARα pool is present in membrane lipid rafts, where it forms complexes with G protein alpha Q (Gαq) in response to RA. This rapid RA-induced formation of RARα/Gαq complexes in lipid rafts is required for the activation of p38MAPK that occurs in response to RA. Accordingly, in RA-resistant cancer cells, characterized by the absence of p38MAPK activation, RARα present in membrane lipid rafts does not associate with Gαq, pointing out the essential contribution of RARα/Gαq complexes in RA signaling.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22056876     DOI: 10.1038/onc.2011.499

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  39 in total

1.  Cullin 3 mediates SRC-3 ubiquitination and degradation to control the retinoic acid response.

Authors:  Christine Ferry; Samia Gaouar; Benoit Fischer; Marcel Boeglin; Nicodeme Paul; Eric Samarut; Aleksandr Piskunov; Gabriella Pankotai-Bodo; Laurent Brino; Cecile Rochette-Egly
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-06       Impact factor: 11.205

2.  Retinoic acid and 6-formylindolo(3,2-b)carbazole (FICZ) combination therapy reveals putative targets for enhancing response in non-APL AML.

Authors:  Rodica P Bunaciu; Robert J MacDonald; Holly A Jensen; Feng Gao; Xin Wang; Lynn Johnson; Jeffrey D Varner; Andrew Yen
Journal:  Leuk Lymphoma       Date:  2018-12-20

3.  Retinoid receptor-based signaling plays a role in voltage-dependent inhibition of invertebrate voltage-gated Ca2+ channels.

Authors:  Eric de Hoog; Mark K Lukewich; Gaynor E Spencer
Journal:  J Biol Chem       Date:  2019-05-02       Impact factor: 5.157

4.  p38 MAPK signaling mediates retinoic acid-induced CD103 expression in human dendritic cells.

Authors:  Mandi M Roe; Marziah Hashimi; Steve Swain; Krista M Woo; Diane Bimczok
Journal:  Immunology       Date:  2020-09-14       Impact factor: 7.397

5.  Alterations of intercellular junctions in peritoneal mesothelial cells from patients undergoing dialysis: effect of retinoic Acid.

Authors:  Carmen Retana; Elsa Sanchez; Alejandro Perez-Lopez; Armando Cruz; Jesus Lagunas; Carmen Cruz; Socorro Vital; Jose L Reyes
Journal:  Perit Dial Int       Date:  2014-03-01       Impact factor: 1.756

Review 6.  Molecular pathways: current role and future directions of the retinoic acid pathway in cancer prevention and treatment.

Authors:  Roisin M Connolly; Nguyen K Nguyen; Saraswati Sukumar
Journal:  Clin Cancer Res       Date:  2013-01-15       Impact factor: 12.531

Review 7.  Vitamin A signaling and homeostasis in obesity, diabetes, and metabolic disorders.

Authors:  William S Blaner
Journal:  Pharmacol Ther       Date:  2019-01-29       Impact factor: 12.310

8.  Differential effects of retinoids and inhibitors of ERK and p38 signaling on adipogenic and myogenic differentiation of P19 stem cells.

Authors:  Frédéric Bouchard; Joanne Paquin
Journal:  Stem Cells Dev       Date:  2013-04-01       Impact factor: 3.272

Review 9.  Vitamin A and retinoid signaling: genomic and nongenomic effects.

Authors:  Ziad Al Tanoury; Aleksandr Piskunov; Cécile Rochette-Egly
Journal:  J Lipid Res       Date:  2013-02-24       Impact factor: 5.922

Review 10.  Retinoids and rexinoids in cancer prevention: from laboratory to clinic.

Authors:  Iván P Uray; Ethan Dmitrovsky; Powel H Brown
Journal:  Semin Oncol       Date:  2015-09-25       Impact factor: 4.929

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.